Fatty Liver News and Research

Latest Fatty Liver News and Research

From diabetes drug to anti-inflammation powerhouse: The unexpected evolution of GLP-1

Research pioneer Dr. Daniel Drucker has much to be proud of, as the GLP-1-based diabetes drugs hailing from his early research are named 2023 breakthrough of the year by the Science Magazine.

18 Dec 2023

Study shows synergistic effects of genetic factors, binge drinking, and diabetes in alcohol-related cirrhosis

Researchers investigated associations between alcohol consumption behaviors, diabetes mellitus, genetic predispositions, and ARLD incidence in 312,59 active drinkers from the United Kingdom Biobank.

18 Dec 2023

Study finds key gene deletion shields mice from diet-induced obesity and liver disease

Study in the International Journal of Obesity reveals that BMAL1 deletion in mice protects against obesity and non-alcoholic fatty liver disease caused by a high-fat diet, highlighting its potential as a therapeutic target.

13 Dec 2023

Tirzepatide maintains weight loss and improves cardiometabolic health in SURMOUNT-4 trial

The current class of anti-obesity drugs is proving remarkably effective at removing excess pounds. However, a phase 3 randomized clinical trial led by researchers at Weill Cornell Medicine and NewYork-Presbyterian found that people who stopped taking the medication regained much of that weight within a year.

11 Dec 2023

Intestine epithelium-derived exosomes serve as novel mediator in regulating hepatic lipid metabolism

Non-alcoholic fatty liver disease (NAFLD), characterized by excessive hepatic lipid accumulation, poses a high prevalence and can progress to cirrhosis and liver cancer.

11 Dec 2023

Is there an association between meat and fish consumption and non-alcoholic fatty liver disease?

The associations between meat and fish consumption and the risk of non-alcoholic fatty liver disease (NAFLD).

11 Dec 2023

Study explores the intricate gut-brain-liver connection and its impact on health

Study reviews the gut-brain-liver axis, revealing the complex interplay between these organs in health and disease and the implications for therapeutic interventions, focusing on how gut microbiota affects liver and brain health.

10 Dec 2023

Study identifies new target for fatty liver disease treatment

The global rise in obesity and diabetes is leading to an epidemic in fatty liver disease affecting 20-30 per cent of the world's population.

7 Dec 2023

New insights into the cellular programs that promote resolution of inflammation during aging

Aging is associated with chronic, nonresolving inflammation, or "inflammaging," that can lead to tissue dysfunction.

6 Dec 2023

Sympathetic nervous system and immune interplay: Key to metabolic regulation

A review in Advanced Science explores the interaction between the immune system and the sympathetic nervous system in regulating vital metabolic organs like the pancreas, liver, and adipose tissues. This comprehensive analysis provides insights into the neuroimmune relationships affecting metabolism, offering potential new therapeutic strategies for metabolic diseases.

5 Dec 2023

Silencing galectin 1 protein shrinks liver cancer tumors in mice

Researchers at UC Davis Comprehensive Cancer Center have shown that inhibiting a specific protein using gene therapy can shrink hepatocellular carcinoma (HCC) in mice.

30 Nov 2023

Study identifies key markers for early detection of fatty liver disease in obese and non-obese individuals

In a study published in 'Scientific Reports', researchers found that insulin resistance markers TyG-BMI and HOMA-IR effectively predict non-alcoholic fatty liver disease (NAFLD) risks in non-obese and obese individuals without diabetes, respectively. These findings suggest new, non-invasive methods for early NAFLD detection, particularly in atypical non-obese cases.

26 Nov 2023

Reducing cholesterol esters protects the brain against Alzheimer's-like damage

In Alzheimer's disease and related dementias, cognitive decline is driven by the overaccumulation of a normal brain protein known as tau.

22 Nov 2023

Excessive diet soft drink consumption is associated with the occurrence of liver disease

The association between diet soft drink intake and metabolic dysfunction-associated steatotic liver disease (MASLD).

22 Nov 2023

Study finds increased liver cancer risk among Mexican Americans in subsequent generations

In the United States, liver cancer rates have more than tripled since 1980. Some groups, including Latinos, face an even higher risk than the general population-;but researchers do not fully understand why.

20 Nov 2023

Study links lifestyle choices and gender to severity of fatty liver disease in workers

Study investigates the correlation between lifestyle factors, gender, inflammation, liver dysfunction, and metabolic abnormalities with fatty liver disease severity, revealing that men are at higher risk and lifestyle choices significantly impact the disease's progression.

15 Nov 2023

Breakthrough study: inhibiting USP30 gene offers hope in treating Parkinson’s disease

Whether USP30 inhibition can serve as a disease-modifying therapy for Parkinson's disease (PD).

15 Nov 2023

Common liver disease expected to rise sharply in next 25 years

The most common form of chronic liver disease is expected to steadily rise over the next 25 years, adding significant burden to the medical system as a new model predicts nearly twice as many liver cancers and almost triple the need for liver transplantation by 2050, according to a study scheduled for presentation at The Liver Meeting, held by the American Association for the Study of Liver Diseases.

7 Nov 2023

Study shows link between food insecurity and liver disease in teens

Teens from low-income families experiencing food insecurity are developing the most common form of liver disease twice as often as those who have easier access to food, likely because they rely on low-cost, ultra-processed foods, according to a study scheduled for presentation at The Liver Meeting, held by the American Association for the Study of Liver Diseases.

7 Nov 2023

New insights into the pathogenesis of chronic liver diseases

Fatty liver diseases (FLD) have become a significant health concern worldwide, affecting millions. The two most common types of FLD are non-alcoholic fatty liver disease (NAFLD) and alcoholic-associated liver disease (ALD). NAFLD is associated with obesity, insulin resistance, and metabolic syndrome, while ALD is caused by excessive alcohol consumption.

7 Nov 2023

Fatty Liver News and Research

Latest Fatty Liver News and Research

From diabetes drug to anti-inflammation powerhouse: The unexpected evolution of GLP-1

Study shows synergistic effects of genetic factors, binge drinking, and diabetes in alcohol-related cirrhosis

Study finds key gene deletion shields mice from diet-induced obesity and liver disease

Tirzepatide maintains weight loss and improves cardiometabolic health in SURMOUNT-4 trial

Intestine epithelium-derived exosomes serve as novel mediator in regulating hepatic lipid metabolism

Is there an association between meat and fish consumption and non-alcoholic fatty liver disease?

Study explores the intricate gut-brain-liver connection and its impact on health

Study identifies new target for fatty liver disease treatment

New insights into the cellular programs that promote resolution of inflammation during aging

Sympathetic nervous system and immune interplay: Key to metabolic regulation

Silencing galectin 1 protein shrinks liver cancer tumors in mice

Study identifies key markers for early detection of fatty liver disease in obese and non-obese individuals

Reducing cholesterol esters protects the brain against Alzheimer's-like damage

Excessive diet soft drink consumption is associated with the occurrence of liver disease

Study finds increased liver cancer risk among Mexican Americans in subsequent generations

Study links lifestyle choices and gender to severity of fatty liver disease in workers

Breakthrough study: inhibiting USP30 gene offers hope in treating Parkinson’s disease

Common liver disease expected to rise sharply in next 25 years

Study shows link between food insecurity and liver disease in teens

New insights into the pathogenesis of chronic liver diseases

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Fatty Liver News and Research

Latest Fatty Liver News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in